Description
Syneron Candela Profound
Masterfully rebuild the skin matrix.
Up to 5x more elastin, up to 2x more collagen, and increased hyaluronic acid.1,2

As we age, skin loses its elasticity. 3 key reasons facial wrinkles and the appearance of cellulite increase(3):Collagen levels decrease every year
Elastin production stops
Hyaluronic acid diminishes
Why Consider the Profound System?
Patients seek treatments that:
- Are less painful and invasive than surgery
- Offer an alternative to the use of toxins and fillers
- Require more manageable downtime
The Profound® system provides a non-surgical alternative to address aging skin:
Using radiofrequency (RF) injectable energy, it provides long-lasting facial wrinkle reduction and improves the appearance of cellulite.4,5

Key Benefits of Profound RF Microneedling
The Profound system can help your practice:
Fill the treatment gap that exists between dermal injectables and invasive surgery
- Adopt new patients in advance of surgery
- Retain existing patients who are not ready for surgical procedures
- Increase revenue with complementary treatments and future procedures
Bottom line:
The Profound system enhances aesthetics practices by providing a clinically proven, non-surgical, single-treatment procedure1,4,5 that requires less practice expense and patient downtime.
Profound RF is a One-of-a-Kind Wrinkle & Cellulite Treatment System
8 facts that make this a one-of-a-kind, must-have system.
- Clinically proven to create all 3 skin fundamentals: up to 5x more elastin, up to 2x more collagen, and increased hyaluronic acid.1,4
- First and only RF microneedling device with FDA clearance for face and body4
- Just one non-surgical treatment required to achieve lasting results2,4,5,6
- 100% response rate for facial wrinkles5,7
- 94% response rate for improvement in the appearance of cellulite4,7,8
- Reduces the appearance of cellulite severity with only one non-surgical treatment4,8,9
- The only real-time, temperature-controlled RF microneedling device4
- Proven in 8 comprehensive clinical studies10